Stephan Lüders Selected Research

Stephan Lüders Research Topics

Disease

20	Hypertension (High Blood Pressure) 11/2023 - 01/2003
12	Stroke (Strokes) 10/2015 - 07/2003
3	Cognitive Dysfunction 10/2015 - 12/2003
3	Essential Hypertension 01/2014 - 07/2008
2	Diabetes Mellitus 11/2023 - 03/2006
1	Obesity 11/2023
1	COVID-19 11/2023
1	Body Weight (Weight, Body) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Weight Loss (Weight Reduction) 12/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Kidney Diseases (Kidney Disease) 08/2017
1	Hypercholesterolemia 08/2017
1	Hyperlipidemias (Hyperlipidemia) 08/2017
1	Chronic Renal Insufficiency 08/2017
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2017
1	Albuminuria 01/2016
1	Dementia (Dementias) 10/2015
1	Renal Insufficiency (Renal Failure) 02/2011
1	Hypotension (Low Blood Pressure) 02/2011
1	Myocardial Infarction 12/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2010
1	Cough 07/2008
1	Ischemic Stroke 01/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2007
1	Proteinuria 03/2006
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2003
1	Transient Ischemic Attack 12/2003
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 12/2003
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2003

Drug/Important Bio-Agent (IBA)

12	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 12/2003
4	candesartanIBA 01/2014 - 10/2010
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2008 - 01/2003
3	AlbuminsIBA 08/2017 - 03/2006
3	Ramipril (Altace)FDA LinkGeneric 01/2012 - 03/2006
3	Angiotensin Receptor AntagonistsIBA 02/2011 - 01/2007
3	NitrendipineIBA 09/2009 - 03/2005
3	eprosartan (Teveten)FDA Link 09/2009 - 03/2005
2	Lipoprotein(a)IBA 12/2021 - 08/2017
2	CreatinineIBA 01/2016 - 12/2010
2	olmesartanIBA 01/2014 - 11/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 01/2014 - 11/2013
2	DiureticsIBA 01/2012 - 12/2003
2	C-Reactive ProteinIBA 12/2010 - 07/2008
2	Irbesartan FDA LinkGeneric 12/2010 - 01/2007
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 07/2008 - 01/2007
2	AngiotensinsIBA 12/2003 - 07/2003
1	Nicotine FDA Link 11/2023
1	LDL CholesterolIBA 11/2023
1	SodiumIBA 11/2019
1	Ezetimibe (Zetia)FDA Link 08/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2017
1	Cystatin CIBA 01/2016
1	pro-brain natriuretic peptide (1-76)IBA 12/2010
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2010
1	Fibrinogen (Factor I)FDA Link 07/2008
1	ThiazidesIBA 07/2008
1	antineoplaston A10 (A 10)IBA 07/2008
1	Losartan (Cozaar)FDA LinkGeneric 07/2008
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2007
1	Proteins (Proteins, Gene)FDA Link 03/2006
1	Angiotensin II Type 1 Receptor BlockersIBA 06/2005
1	CalciumIBA 06/2005
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2003
1	candesartan cilexetil (Amias)FDA Link 07/2003

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2003
7	Secondary Prevention 11/2023 - 12/2003
2	Blood Pressure Monitors 10/2019 - 12/2012
1	Polypharmacy 11/2019
1	Denervation 01/2016
1	Drug Therapy (Chemotherapy) 01/2007